Product categoriesPersonal Care (Topical)

Products 1 to 10 of 20

ActoBiotics: AG013 (Oral Mucositis) by Actobio Therapeutics
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (2 months ago)
Date last modified: 2019/09/12 15:12 (2 months ago)
Known funding amount: N/A
Funding types: Government + Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Personal Care (Topical) + Medicine
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
ActoBiotics: AG018 (Rhinosinusitus) by Actobio Therapeutics
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (2 months ago)
Date last modified: 2019/09/12 15:12 (2 months ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (2 months ago)
Date last modified: 2019/09/12 15:12 (2 months ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
AZT-01 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:14 (2 months ago)
Date last modified: 2019/09/12 15:14 (2 months ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
AZT-02 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:14 (2 months ago)
Date last modified: 2019/09/12 15:14 (2 months ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
AZT-04 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:15 (2 months ago)
Date last modified: 2019/09/12 15:15 (2 months ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
AZT-05 by Azitra
Biotech components: Bacteria
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:14 (2 months ago)
Date last modified: 2019/09/12 15:14 (2 months ago)
Known funding amount: N/A
Funding types: Government + Private Funding
Industry: Health + Medical
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: N/A
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Clearwood (TM) Patchouli Oil by Amyris + Firmenich
Biotech components: Plant
Business models: B2C
Country of production: USA + Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (1 year ago)
Date last modified: 2019/02/15 12:43 (9 months ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (1 year ago)
Date last modified: 2018/10/02 11:41 (1 year ago)
Known funding amount: 909,000 USD
Funding types: Crowdfunding + Private Funding
Industry: Health
Market status: No longer on the market
Organization type(s): Private Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Lux Algal Oil Soap by Lux (Unilever)
Biotech components: Plant
Business models: B2C
Country of production: UK
Country of distribution: Brazil + UK
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (1 year ago)
Date last modified: 2018/08/30 11:49 (1 year ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: ULVR (LSE)
Value chain stage: Finished Product